ABNORMAL UTERINE BLEEDING AS A PREDICTOR FOR ENDOMETRIAL ABNORMALITIES, QUICK DIAGNOSIS OF PREMALIGNANT AND MALIGNANT STATES AND THE IMPACT OF VARIOUS RISK FACTORS
Keywords:
#abnormal uterine bleeding #dilatation and curettage #transvaginal ultrasound #risk factorsAbstract
Approximately 30% of women will experience abnormal uterine bleeding (AUB) during their lifetime. It is a common medical problem, with a direct influence on women's quality of life, utilization of health care resources, and costs.
The aim of this study was to analyze the histopathological findings of the samples from dilatation and curettage (D&C) in patients with abnormal uterine bleeding and to determine the presence of certain risk factors (age, obesity, hypertension, diabetes, parity) in the examined groups.
This was a prospective study including a total of 77 patients from the Department of Gynecology and Obstetrics in PHI General Hospital Gevgelija, who underwent D&C in 2021. Data were collected through interviews and analysis of findings from histopathological analyses of samples obtained by D&C. The following anamnestic data were analyzed: age, parity, history of hypertension and diabetes. Weight and height were measured in all patients.
The most common pathological change of the endometrium was endometrial polyp. The second most common histopathological diagnosis in premenopausal women was anovulatory bleeding vs. menopausal women who were secondly frequent diagnosed with endometrial hyperplasia. Gynecological cancers were more common in menopausal age. Various anamnestic factors were differently related to various histopathological diagnoses.
All patients that report abnormal uterine bleeding are diagnosed with endometrial abnormalities by TVUS and should undergo D&C for quick diagnosis of premalignant and malignant states of the genital tract. By reducing body weight, regulating hypertension and diabetes, the risk of the most severe pathological diagnosis is reduced.
References
Davis E, Sparzak PB. Abnormal Uterine Bleeding. Treasure Island (FL): StatPearls Publishing 2022.
Khafaga A, Goldstein SR. Abnormal Uterine Bleeding. Obstet Gynecol Clin North Am 2019; 46(4): 595-605. doi: 10.1016/j.ogc.2019.07.001.
Deneris A. PALM-COEIN Nomenclature for Abnormal Uterine Bleeding. J Midwifery Womens Health 2016; 61(3): 376-379. doi: 10.1111/jmwh.12440.
Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update 1998; 4(4): 312-322. doi: 10.1093/humupd/4.4.312.
Patterson-Keels LM, Selvaggi SM, Haefner HK, Randolph JF Jr. Morphologic assessment of endometrium overlying submucosal leiomyomas. J Reprod Med 1994; 39(8): 579-584. PMID: 7996520.
DiSaia PJ, Creasman WT. Clinical gynecologic oncology 7th ed. 2007 Mosby Inc.
Edlund M, Blombäck M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53(4): 234-238. doi: 10.1002/(SICI)1096-8652(199612)53:4<234: AID-AJH4>3.0.CO;2-Z.
Taylor HS, Pal L, Seli E. Speroff’s clinical gynecologic endocrinology an infertility 9th ed. 2020. Wolters Kluwer.
Berek JS. Berek & Novak’s Gynecology 14th ed. 2007. Wolters Kluwer.
DeCherney A, Nathan L, Laufer N, Roman AS. Current diagnosis & treatment Obstetrics and Gynecology 11th ed. 2013. McGraw-Hill Companies.
Hashim H, Nawawi O. Uterine arteriovenous malformation. Malays J Med Sci 2013; 20(2): 76-80. PMID: 23983582.
Kocevska A, Skeparovska K. Spectrum of histopathologicalchanges of the endometrium in patients with abnormal uterine bleeding. Medicus 2021. ISSN 1409-6366 UDC 61 Vol · 26(1) (page 66-71).
Lieng M, Istre O, Qvigstad E. Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand 2010; 89(8): 992-1002. doi: 10.3109/00016349.2010.493196.
Serhat E, Cogendez E, Selcuk S, Asoglu MR, Arioglu PF, Eren S. Is there a relationship between endometrial polyps and obesity, diabetes mellitus, hypertension? Arch Gynecol Obstet 2014; 290(5): 937-941. doi: 10.1007/s00404-014-3279-4.
Wong M, Thanatsis N, Nardelli F, Amin T, Jurkovic D. Risk of Pre-Malignancy or Malignancy in Postmenopausal Endometrial Polyps: A CHAID Decision Tree Analysis. Diagnostics (Basel) 2021; 11(6): 1094. doi: 10.3390/diagnostics11061094.
Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996; 81(4): 1495-501. doi: 10.1210/jcem.81.4.8636357.
Slap GB. Menstrual disorders in adolescence. Best Pract Res Clin Obstet Gynaecol 2003; 17(1): 75-92. doi: 10.1053/ybeog.2002.0342.
Chung HF, Ferreira I, Mishra GD. The association between menstrual symptoms and hypertension among young women: A prospective longitudinal study. Maturitas 2021; 143: 17-24. doi: 10.1016/j.maturitas.2020.08.006.
Lacey JV Jr, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, Duggan MA, et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol 2010; 10; 28(5): 788-792. doi: 10.1200/JCO.2009. 24.1315.
Barboza IC, Depes Dde B, Vianna Júnior I, Patriarca MT, Arruda RM, Martins JA, et al. Analysis of endometrial thickness measured by transvaginal ultrasonography in obese patients. Einstein (Sao Paulo) 2014; 12(2): 164-167. doi: 10.1590/s1679-45082014ao2838.
Tekalegn Y, Sahiledengle B, Woldeyohannes D, Atlaw D, Degno S, Desta F, et al. High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case-control studies. Womens Health (Lond) 2022; 18: 17455065221075904. doi: 10.1177/17455065221075904.
Nappi L, Indraccolo U, Di Spiezio Sardo A, Gentile G, Palombino K, Castaldi MA, et al. Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps? J Minim Invasive Gynecol 2009; 16(2): 157-162. doi: 10.1016/j.jmig.2008.11.004.
